chrisvoncsefalvay/vaers-outcomes huggingface dataset:
miscarriage; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (RA).  A female patient (pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABORTION SPONTANEOUS (medically significant), outcome "unknown", described as "miscarriage". The pregnancy resulted in spontaneous abortion. Clinical course: The caller said his ex-girlfriend actually had a miscarriage.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, Diarrhea & NauseaVomiting Narrative:  Other Relevant History:
Began developing allergic reaction on face to all facial products. After vaccine my blood work indicated I could have Lupus. Further testing indicated I do not have Lupus but I am vulnerable to blood clots. Still have several appointments with multiple doctors, trying to get answers. Developed Kidney stones in September of 2021. Unsure if related to vaccines or not.
Information has been received from a licensed practical nurse (LPN) concerning a female infant who on 15-SEP-2008 was vaccinated PO with a dose of ROTATEQ. On 15-SEP-2008, the LPN reported that the infant received an incomplete vaccine dose because of spitting up during the administration. The patient sought unspecified medical attention. The LPN reported the outcome as recovered on 15-SEP-2008. A product quality complaint was not involved. No further information is available.
CONFIRMED CLINICAL VACCINATION FAILURE; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 66 year old male. Initial information was processed along with the additional information received on 09-JAN-2023. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergy (unspecified drug). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 01 total administered on 08-MAR-2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 64 years old. Concomitant medications included atorvastatin and Zetiamid from 01-JAN-2022 to 12-DEC-2022 for an unspecified indication. The patient additionally received a non-company suspect vaccine included: elasomeran (Moderna) (Dose number in series 2) (form of admin, route of admin, batch number and expiry were not reported) dose was not reported, administered on 10-NOV-2021 for covid-19 prophylaxis. It was unknown whether the patient experienced any adverse events following vaccination with elasomeran (Dose number in series 2) The patient again received a non-company suspect vaccine included: elasomeran (Moderna) (Dose number in series 3) (form of admin, route of admin, batch number and expiry were not reported) dose was not reported, administered at left arm on 13-SEP-2022 at 09:30 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (Dose number in series 3).  On 13-DEC-2022, Laboratory data included: COVID-19 virus test Positive (confirmed clinical vaccination failure, Dose number in series 1). Treatment medication included, Paxlovid for COVID-19 treatment from 13-DEC-2022 to 18-DEC-2022. On 21-DEC-2022, Laboratory data included: COVID-19 virus test Negative, after being symptom free for 3 days.  On 23-DEC-2022 16:00, the patient was symptomatic with chest and nasal congestion (confirmed covid-19 infection / covid rebound, Dose number in series 3) and tested positive on 25-DEC-2022. On 26-DEC-2022, the symptoms were mild, slight sore throat and nasal congestion. Had chest congestion as well the previous 2 days (Dose number in series 3).  The action taken with covid-19 vaccine ad26.cov2.s, elasomeran, and elasomeran was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure and revaccination with different covid-19 vaccine was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000266165.; Sender's Comments: V0: 20230109886-confirmed clinical vaccination failure. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
Severe ringing in my ears; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 27Mar2021 at 03:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. Concomitant medications included atorvastatin calcium (LIPITOR), cetirizine hydrochloride (ZYRTEK), acetylsalicylic acid (BABY ASPIRIN) and allopurinol sodium (ALLOPURINOL); all from an unknown date for unknown indications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 14:00, the patient experienced severe ringing in ears. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events an included treatment with sleep aid because ringing was so loud and could not sleep. The clinical outcome of the event severe ringing in ears was not recovered at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 17Apr2021 at 13:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Patient had PROQUAD and KINRIX, came back into office 30 min later with redness on face, abdominal pain and vomiting, HR 120, low blood O2, EPIPEN Jr given.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS ACUTE DVT OF BILAT ILIAC VEINS 11/4/2022,  2/21/2023,  1/5/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
sensation from the neck down to elbow on left side; This case was reported by a pharmacist via call center representative and described the occurrence of tingling sensation in a 77-year-old female patient who received Herpes zoster (Shingrix) (batch number 7PS9E, expiry date 10th September 2021) for prophylaxis.   On 22nd May 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than a year after receiving Shingrix, the patient experienced tingling sensation. On an unknown date, the outcome of the tingling sensation was not recovered/not resolved.   It was unknown if the reporter considered the tingling sensation to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported on behalf of patient describes tingling sensation from the neck down to elbow on left side only which was the same side of vaccination of shingrix vaccine.  Tingling sensation began at an unknown date and time but occurred after receiving 2nd dose.  Tingling sensation reported as occurring 1-2 times a day, every day, for approximately 5 minutes that has not resolved. The pharmacist unsure of date and time when tingling sensation first occurred following 2nd dose.
Whole body itching/itching all over his body; Headache; Arm sore; Nauseated; Feeling unwell; tired/under the weather for 3 days after the vaccine; This is a spontaneous report from a contactable consumer(parent). A 14-year-old male patient received first dose bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; lot number: EW0176), via an unspecified route of administration on 15May2021 (age at the vaccination was 14-year-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications. On an unknown date May2021, the patient experienced Feeling unwell; tired/under the weather for 3 days after the vaccine. On an unknown date, the reported stated that none of the patient symptoms that were not listed as possible symptoms that confused the reporter was the itching because when the reporter was reading it through a media and reporter was reading carefully and it was not that the patient had itching at the site of the injection but his like whole body was itching. The patient not had a rash or any swelling or anything like that. The patient had a headache, arm sore and nauseated but nothing else other than itching. The reporter stated her son did not had hives or breathing difficulties or any anaphylactic like reactions. The reporter wanted to know was contraindication to getting the Pfizer covid 19 vaccines. No treatment medication was received for the adverse events. The outcome of the event itching was resolved (lasted around 4 days) on an unknown date 2021. The outcome of the other events was unknown.   Follow-up attempts completed. No further information expected.
Nausea; This spontaneous case was reported by a health care professional and describes the occurrence of NAUSEA (Nausea) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history provided.  Concomitant products included ALPRAZOLAM (XANAX SR), ATORVASTATIN CALCIUM (LIPTOR [ATORVASTATIN CALCIUM]) and VITAMINS NOS for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
This is a spontaneous report from a contactable consumer. This same consumer reported similar events for 2 patients. This is the second of 2 reports. A patient of unspecified age and gender received TRUMENBA (lot number and expiration date unknown) and MENACTRA (lot number and expiration date unknown) both via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced flu-like symptoms, fever and rash on the arm all on an unspecified date. The outcome of the event was unknown. The following information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2018492475 same product and event, different patient.
Pt had Pneumovax on 6/24/04. She presented in urgent care center on 6/25/04 with complaints of swelling with diffuse erythema of left upper arm extending distally from shoulder to about 3 inches above elbow. No respiratory difficulty breathing or wheezing noted. Diagnosed as acute allergic reaction. Ruled out cellulitis. Placed on antibiotic.
PATIENT IS 11 YEARS WAS GIVEN THE WRONG VACCINE, PT SHOULD HAVE GOT THE BIVALENT CHILDREN VACCINE SINCE HE IS LESS THAN 12 YEARS OLD AND WAS GIVEN THE REGULAR BIVALENT PFIZER VACCINE
Headache, Sedation, Myalgia, Arthralgia, NauseaVomiting, Chills,Pain/Swelling @ injection site  Narrative:
INCREASED BLOOD PRESSURE; CHEST PAIN; TUNNEL VISION; FAINTNESS; SHOOTING PAINS UNDER LEFT NIPPLE; HEAD IN THE CLOUDS; NOT MENTALLY CLEAR; TINGLING OF FINGERS; FATIGUE; HEADACHE; TINNITUS; HEAD RUSH; DIZZINESS; This spontaneous report received from a patient concerned a 51 year old white not Hispanic or Latino male. The patient's height, and weight were not reported. The patient's concurrent conditions included: egg allergy. The patient had no medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212A21A, and expiry: 21-DEC-2021) dose was not reported, 1 total, administered on 29-SEP-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 29-SEP-2021, the patient experienced dizziness, head rush, tinnitus and headache. On 30-SEP-2021, the patient experienced tunnel vision, faintness, chest pain, shooting pains under left nipple, head in the clouds, not mentally clear, tingling of fingers and fatigue. On 04-OCT-2021, the patient experienced increased blood pressure. The patient stated that he was seen at multiple urgent care facilities looking for steroids for tinnitus but was denied steroid prescription due to elevated blood pressure. Patient also stated that he found article on the internet that suggested steroid treatment for persistent tinnitus. The patient also attempted to self medicate with tylenol and OTC antihistamine but with no success. Laboratory data included: Blood pressure (NR: not provided) Increased. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tunnel vision, chest pain, shooting pains under left nipple, and tingling of fingers on 01-OCT-2021, and had not recovered from tinnitus, dizziness, headache, increased blood pressure, fatigue, head rush, head in the clouds, not mentally clear, and faintness. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20211020198-covid-19 vaccine ad26.cov2.-Tunnel vision, Faintness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Had severe pain from carpal tunnel a day after first shot. fingers remain numb in left hand. got shot in left arm. left hand was way worse than in my right as far as pain and numbness.
Family and dept of health informed of flu shot given at 3 months old. No adverse reactions noted but ineffective. Family cooperative and understanding.
Facial paralysis. In the second dose, 14 days after the vaccine was administered, I had facial paralysis or bell's palsy on the left side of the face, age 44, vaccinated on January 14, 2022 with the Pfizer COVID-19 vaccine. In the 1st dose administered on September 1, 2021 I had rash in the armpits for 5 days, strong tachycardia for 7 days, numbness and tingling left leg when receiving the 1st dose also with 44 years on September 01, 2022 for Pfizer both doses administered in the right arm.
pt recvd vax 17APR91 & 2 days later entire upper arm was swollen, hot, red & had fever of 103; hospitalized; test were neg; observed for several days & discharged on 22APR; arm was better & temp dec;
I developed extreme shoulder pain and weakness in my arm with limited mobility  the evening of my Covid vaccine. I kept trying to move my arm since I thought it was pain from the vaccine dose, but the pain continued to get worse over the week even with ibuprofen. I went to my primary care physician a week after the vaccine and he examined me and said the placement of the injection was much too high and it missed my deltoid muscle. I completed lab work to rule out infection, and I am scheduled to have imaging of my left shoulder to determine the extent of the shoulder injury from the misplaced injection. It has been 2 weeks and the pain is continuing to increase with very limited mobility. I have had to miss work, can't drive my stick shift car, and my sleep is poor because the pain wakes me up during the night.
I broke out with Dermatitis. I went to the Dermatologist. I researched, and he confirmed, that an outbreak of dermatitis could be triggered by a vaccination. None of the other potential triggers were present in my case.
I have ringing in my ears that comes and goes.  Sometimes it is very loud.  It can be in both my ears and other times only in my left ear.  This started days after receiving the second shot.   I still have this condition two months later.   Unknown if this is going to be permanent.
1 day after injection, the injected arm was sore. This was greatly diminished the next day. Some itching at the injection site but very mild. In the evening exactly 7 days after vaccination more itching was noticed. Area felt like one large, flat bump. About 1 inch under the injection site the skin is large, itchy,  and hard, maybe 2 inches in diameter. Area is slightly warm to the touch.
PENTACEL vaccine given on Left Thigh on 11/17/2014. Child developed extensive redness and bruising with 24 hours child was seen at office on 11/19 redness measure 16cm x 8cm extending from injection site with 7cm x 3cm bruising no induration treatment 1 dose of steroid and resolution of redness within 24 hrs seen again on 11/21 with mild bruising no redness on induration child well.
Pt recv vax on 10/21/98; on 10/23/98 pt exp fever, vomiting, headache; tx=Tylenol
I received my second Moderna booster for COVID-19 on 4/11/2022. On the evening of 6/10/2022, I developed a scratchy throat and I felt like I was coming down with a cold. On 6/11/2022, I just felt like I had a cold; my nose wouldn't stop running and I just didn't feel well. I took a home antigen test that night, and I got a positive result. On 6/12/2022, I had a fever of 101.2, a runny nose, and some sneezing. I took Tylenol and slept most of the day, and the fever broke. On 6/13/2022, I just felt tired and still had a runny nose. I felt unwell for about 2-3 days, but I began to feel better on 6/14/2022 and 6/15/2022. On the afternoon of 6/13/2022, I had a telemedicine appointment with my doctor. She offered to prescribe me Paxlovid, but I declined, since I don't have any comorbidities and I didn't feel like I was high-risk. The cold-like symptoms began to subside and I started to regain my energy. I also started to get a dry cough. It wasn't persistent, but I did occasionally treat it by taking OTC cough medicine. At the time of this writing, I still have some residual cough. I took another antigen test on 6/21/2022, and the result was negative. Although I received a negative test result, I still don't feel that I have completely recovered due to the lingering cough. Other than that, though, I'm doing fine.
6 days later I developed a red raised bump at the site of injection with increasing itching. Itching still continued days afterwards
Rash appeared on my shoulder around the injection site on the 5th. I had been in the sun, thought it could just be that I didn?t apply enough sunscreen.  Didn?t really notice any pain or swelling the 6th, almost forgot about it. Today, the 7th, noticed it itching and tender during work. By the evening a noticeably red, slightly elevated rash had appeared. At this point, now 9:30 pm, it is a puffy, tender, red rash about three inches long and two inches wide. What I imagine is the injection site is about a quarter-inch wide dot near the center.  I applied Neosporin and then read that the internet consensus is that "covid arm" is uncommon but not alarming. Hopefully the medical prognosis as well.
Information has been received from a physician concerning an 80 year old female who on an unspecified date was vaccinated with a 0.65 ml dose of Zostavax. Subsequently, about 4 weeks after vaccination the patient developed pericarditis with bloody tamponade. Unspecified medical attention was sought. At the time of the report a work up was in progress. There was no product quality complaint involved. No further information was provided. Additional information has been requested.
From initial information received on 11/12/2003 from a healthcare professional regarding an adverse event occurring in the USA, it was reported that 19 year old female patient received a dose of Fluzone SV '2003-'2004 USP, lot number not reported, administered in her deltoid (route of administration not reported), on an unspecified date.  According to patient's mother, the patient complained of arm pain beginning the evening of injection.  The arm pain has resolved, but shoulder pain persists.  The patient's primary care physician made a diagnosis of bursitis.  Reportedly, the patient did not recover from these events.  No other information was provided at this time. Follow up VAERS form received on 02/23/2004.  No additional information was provided. No further information is anticipated, this case is considered closed.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Jan2021 as dose 1, single (Lot number: EL1283), on 09Feb2021 as dose 2, single (Lot number: EM9810), on 10Sep2021 as dose 3 (booster), single (Lot number: EW0185) and on 02Mar2022 as dose 4 (booster), single (Lot number: FM9895) at the age of 70 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Multiple chronic conditions" (unspecified if ongoing); "immunocompromised" (unspecified if ongoing); "Yes, multiple med allergies" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Result; (04Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient received other medication in 2 weeks. On 20Jun2022, she started oral treatment with Paxlovid for COVID-19 which was stopped on 24Jun2022. Rebound symptoms started on 28Jun2022 (finished course 26Jun2022) and had sinus congestion, headache, still testing positive for Covid on 04Jul2022 on the rapid home antigen tests. The patient had multiple med allergies. Other medical history included multiple chronic conditions, immunocompromised.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
About 5 to 10 minutes after receiving vaccine, patient broke out in a rash. The rash spread throughout the body including face, chest, upper back, wrists, and left leg. Patient was monitored closely for the next 15 minutes at which point some of the rash diminished. Patient was given BENADRYL at 1945.
Acute redness and pain in right arm started within hours after vaccine, subsided after 2 days but then returned about a week later. At that point, a week later, the same area became red, itchy and has a raised welt right where the vaccine was administered. This delayed side effect lasted about another five  days. I expected the initial 1-2 days of pain in my arm but not the delayed reaction a week later.